斩获两连板，翔宇医疗称脑机接口相关产品尚未实现规模化销售

Group 1 - The core point of the article is that Xiangyu Medical (688626) has experienced a significant stock price fluctuation, with a cumulative increase of 30% over three consecutive trading days, triggering an abnormal trading alert according to stock exchange regulations [1] - The recent surge in interest in brain engineering and brain-computer interface concepts has positively impacted the stock prices in this sector, including Xiangyu Medical, which focuses on non-invasive brain-computer interface technology [1] - Xiangyu Medical's current technology and product development in brain-computer interfaces cover various rehabilitation scenarios, but the company acknowledges that its products are not expected to achieve large-scale sales until the end of 2025, resulting in a small revenue contribution at this time [1] Group 2 - The stock price of Xiangyu Medical reached a closing price of 87.12 yuan per share on January 6, with a 20% increase on that day, following two consecutive days of trading limits [1]